PB 81 of 2024

National Health (Listed Drugs on F1 or F2) Amendment Determination 2024 (No. 6)

I, Nikolai Tsyganov, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make the following determination.

Dated           30   July 2024    

NIKOLAI TSYGANOV

Contents

1  Name

2  Commencement

3  Authority

4  Schedules

Schedule 1—Amendments

National Health (Listed Drugs on F1 or F2) Determination 2021 (PB 33 of 2021)

1  Name

(1)  This instrument is the National Health (Listed Drugs on F1 or F2) Amendment Determination 2024 (No. 6).

(2)  This instrument may also be cited as PB 81 of 2024.

2  Commencement

 (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

 (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

  This instrument is made under subsection 85AB(1) of the National Health Act 1953.

4  Schedules

  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Listed Drugs on F1 or F2) Determination 2021 (PB 33 of 2021)

1        Schedule 1, after item dealing with Amino acid formula with carbohydrate without phenylalanine  

omit:

Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without methionine and supplemented with docosahexanoic acid

insert:

Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without methionine and supplemented with docosahexaenoic acid

2        Schedule 1, after item dealing with Amino acid formula with fat, carbohydrate, vitamins, minerals, trace elements and medium chain triglycerides    

omit:

Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine and tyrosine and supplemented with docosahexanoic acid    

insert:

Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine and tyrosine and supplemented with docosahexaenoic acid   

3        Schedule 1, after item dealing with Amino acid formula with vitamins and minerals without valine, leucine and isoleucine  

omit:

Amino acid formula with vitamins and minerals without valine, leucine and isoleucine with fat, carbohydrate and trace elements and supplemented with docosahexanoic acid     

insert:

Amino acid formula with vitamins and minerals without valine, leucine and isoleucine with fat, carbohydrate and trace elements and supplemented with docosahexaenoic acid  

4        Schedule 1, after item dealing with Oxcarbazepine

omit:

Oxprenolol   

5        Schedule 1, after item dealing with Patiromer

insert:

Patisiran    

6        Schedule 1, after item dealing with Selinexor

insert:

Selumetinib     

7        Schedule 1, after item dealing with Tafamidis  

omit:

Tafluprost